首页 > 最新文献

Surgery, Gastroenterology and Oncology最新文献

英文 中文
Literature Review of Oropahyngeal Cancer Patients Assessed with EORTC QLQ-30 EORTC HN-35# 用EORTC QLQ-30和EORTC HN-35#评价口咽癌患者的文献综述
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.21614/sgo-477
A. Diaconescu, Jvalant N Parekh, Valeriu Buza
Background: Oropharyngeal cancer is the most common type of head and neck cancers, with a 5-years survival of 64.7%. In the last 40 years risk factors and etiology changed, from the incidence associated mostly with tobacco and alcohol to HPV infection in 70% of the cases. Treatments that are standard of care for OPSCC include chemotherapy, radiotherapy or combination of surgery and radiotherapy have a high chronic treatment-related toxicity and functional loss. These therapies have significant impact on the quality of life (QOL) of survivors of oropharyngeal squamous cell carcinoma (OPSCC). Objectives: The objective of this study is to review literature on 1-year evolution of quality of life of patients treated for OPSCC with standard of care. Methods: A comprehensive search of the literature of treated OPSCC patients assessed with EORTC QLQ-30 EORTC H&N-35 at pre-treatment 12-month post treatment. Results: The first study showed that standard of care treatment produces chronic side effects, such as xerostomia, poor oral and dental health, dysphagia, feeding tube dependency in, and other fibrotic changes likely caused by radiotherapy or combination of surgery and radiotherapy. Conclusions: Standard of care treatment produces chronic side effects, such as xerostomia, poor oral and dental health, dysphagia, feeding tube dependency in, and other fibrotic changes.
背景:口咽癌是头颈部肿瘤中最常见的类型,5年生存率为64.7%。在过去40年中,风险因素和病因发生了变化,从主要与烟草和酒精相关的发病率到70%的病例中HPV感染。OPSCC的标准治疗包括化疗、放疗或手术和放疗的联合治疗,这些治疗具有很高的慢性治疗相关毒性和功能丧失。这些疗法对口咽鳞状细胞癌(OPSCC)幸存者的生活质量(QOL)有显著影响。目的:本研究的目的是回顾有关标准护理治疗OPSCC患者1年生活质量演变的文献。方法:综合检索经治疗的OPSCC患者在治疗前12个月用EORTC QLQ-30 EORTC H&N-35进行评估的文献。结果:第一项研究表明,标准护理治疗会产生慢性副作用,如口干、口腔和牙齿健康状况不佳、吞咽困难、喂食管依赖,以及其他可能由放疗或手术与放疗联合引起的纤维化改变。结论:标准护理治疗会产生慢性副作用,如口干、口腔和牙齿健康状况差、吞咽困难、饲管依赖等纤维化改变。
{"title":"Literature Review of Oropahyngeal Cancer Patients Assessed with EORTC QLQ-30 EORTC HN-35#","authors":"A. Diaconescu, Jvalant N Parekh, Valeriu Buza","doi":"10.21614/sgo-477","DOIUrl":"https://doi.org/10.21614/sgo-477","url":null,"abstract":"Background: Oropharyngeal cancer is the most common type of head and neck cancers, with a 5-years survival of 64.7%. In the last 40 years risk factors and etiology changed, from the incidence associated mostly with tobacco and alcohol to HPV infection in 70% of the cases. Treatments that are standard of care for OPSCC include chemotherapy, radiotherapy or combination of surgery and radiotherapy have a high chronic treatment-related toxicity and functional loss. These therapies have significant impact on the quality of life (QOL) of survivors of oropharyngeal squamous cell carcinoma (OPSCC). Objectives: The objective of this study is to review literature on 1-year evolution of quality of life of patients treated for OPSCC with standard of care. Methods: A comprehensive search of the literature of treated OPSCC patients assessed with EORTC QLQ-30 EORTC H&N-35 at pre-treatment 12-month post treatment. Results: The first study showed that standard of care treatment produces chronic side effects, such as xerostomia, poor oral and dental health, dysphagia, feeding tube dependency in, and other fibrotic changes likely caused by radiotherapy or combination of surgery and radiotherapy. Conclusions: Standard of care treatment produces chronic side effects, such as xerostomia, poor oral and dental health, dysphagia, feeding tube dependency in, and other fibrotic changes.","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89439385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Closer Look: Assessment of Acute Pancreatitis Prognosis Using Neutrophil-Lymphocyte Ratio 用中性粒细胞-淋巴细胞比值评估急性胰腺炎预后
Q4 Medicine Pub Date : 2021-06-30 DOI: 10.21614/sgo-26-2-296
T. Fonseca, João Miranda, Vítor Devezas, Marisa Aral, Rui Mendes Costa, J. Costa Maia
Background/Objectives: Acute pancreatitis (AP) is a common cause of hospitalization and severe cases are usually associated with a poor prognosis. Neutrophil to lymphocyte ratio(NLR) has been pointed as an indicator of systemic inflammation in several disorders. The aim of this study was to assess whether NLR at admission is able to predict severity of AP and some associated outcomes, while trying to establish the best cut-off value for
背景/目的:急性胰腺炎(AP)是住院治疗的常见原因,严重者通常伴有不良预后。中性粒细胞与淋巴细胞比率(NLR)已被认为是几种疾病中全身性炎症的指标。本研究的目的是评估入院时NLR是否能够预测AP的严重程度和一些相关结果,同时试图建立最佳临界值
{"title":"A Closer Look: Assessment of Acute Pancreatitis Prognosis Using Neutrophil-Lymphocyte Ratio","authors":"T. Fonseca, João Miranda, Vítor Devezas, Marisa Aral, Rui Mendes Costa, J. Costa Maia","doi":"10.21614/sgo-26-2-296","DOIUrl":"https://doi.org/10.21614/sgo-26-2-296","url":null,"abstract":"Background/Objectives: Acute pancreatitis (AP) is a common cause of hospitalization and severe cases are usually associated with a poor prognosis. Neutrophil to lymphocyte ratio(NLR) has been pointed as an indicator of systemic inflammation in several disorders. The aim of this study was to assess whether NLR at admission is able to predict severity of AP and some associated outcomes, while trying to establish the best cut-off value for","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73454987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laparoscopic Right Adrenalectomy for a Large Adrenal Tumor Combined with in situ Ablation of a Hepatic Nodule in a Cirrhotic Patient 腹腔镜右肾上腺切除术治疗肝硬化大肾上腺瘤合并原位消融术一例
Q4 Medicine Pub Date : 2021-06-30 DOI: 10.21614/sgo-26-2-362
Mirela Patricia Sîrbu Boeți, Andrei Marius Baicu, M. Toma, V. Herlea, L. Iliescu
Introduction: Cirrhotic patients are difficult patients to operate on and are generally considered unsuitable for laparoscopy (1,2). We present the clinical case of a cirrhotic patient with comorbidities that was diagnosed with a hepatic nodule and cortisol secreting right adrenal tumor, for which a multidisciplinary team decided to submit him for laparoscopic intervention. Case report: N.D. is a 59 y.o. male, diagnosed in 2010 with alcoholic Child-Pugh B liver cirrhosis (score 9). In February 2019, a hepatic nodule in segment IV-A (2 cm) and cortisol secreting right adrenal tumor (6/4/4 cm) were found. He is also diagnosed with essential arterial hypertension grade II, mild diastolic dysfunction of the left ventricle, aortic sclerosis, chronic ischemic cardiomyopathy, type 2 diabetes mellitus and chronic gastritis. He had laparoscopic cholecystectomy in 2000. The hepatic nodule in segment IV-A was highly suggestive of hepatocellular carcinoma due to imaging characteristics. Subclinical secretion of cortisol was present (low ACTH 4.18 pg/ml, normal plasmatic cortisol, metanephrine, normetanephrine). AFP, CEA, CA 19-9 were normal. The patient underwent surgery on 27 May 2019. Adhesiolysis, transperitoneal laparoscopic right adrenalectomy and alcoholization of hepatic tumor have been performed. Radiofrequency ablation of the hepatic tumor was preoperatively anticipated but was intraoperatively abandoned in favor of in situ hepatic tumor ablation with percutaneous ethanol injection due to encountered metabolic acidosis and cardiac arrhythmia. Results: Postoperatively the patient developed hemorrhagic ascites and abdominal wall hematoma that were successfully controlled by conservative measurements. He was discharged on the 15 th postoperative day. Histopathology found cortical-adrenal adenoma with clear cells. The patient was completely withdrawn from corticosteroids in October 2019. On October 1st, 2019, transarterial chemoembolization (TACE) with Gelaspon, Lipidol and Doxorubicin was performed to completely ablate the hepatic nodule. After two years the patient had Child-Pugh B cirrhosis (score 7) with no tumor recurrence. Conclusion: Laparoscopic right adrenalectomy could be safely performed for a right adrenal tumor in a Child-Pugh B cirrhotic patient with other comorbidities but the percutaneous alcoholization of the hepatic nodule under video and ultrasound guidance needed TACE for its complete destruction.
简介:肝硬化患者是难以手术的患者,一般认为不适合腹腔镜手术(1,2)。我们提出一个临床病例的肝硬化患者的合并症,被诊断为肝结节和皮质醇分泌右肾上腺肿瘤,为此多学科团队决定提交他腹腔镜干预。病例报告:N.D., 59岁男性,2010年诊断为酒精性Child-Pugh B型肝硬化(评分9)。2019年2月,发现IV-A段肝结节(2cm)和分泌皮质醇的右侧肾上腺肿瘤(6/4/4 cm)。他还被诊断患有II级原发性动脉高血压、左心室轻度舒张功能障碍、主动脉硬化、慢性缺血性心肌病、2型糖尿病和慢性胃炎。他在2000年做了腹腔镜胆囊切除术。IV-A段肝结节的影像学特征高度提示肝细胞癌。存在亚临床皮质醇分泌(低ACTH 4.18 pg/ml,血浆皮质醇、肾上腺素、去甲肾上腺素正常)。AFP、CEA、ca19 -9正常。患者于2019年5月27日接受手术。应用粘连松解术、经腹腔腹腔镜右肾上腺切除术和肝肿瘤酒精化治疗。术前预期对肝肿瘤进行射频消融,但术中由于遇到代谢性酸中毒和心律失常,转而采用经皮乙醇注射原位肝肿瘤消融。结果:术后患者出现出血性腹水和腹壁血肿,经保守措施控制。术后第15天出院。组织病理学发现皮质肾上腺腺瘤,细胞透明。该患者于2019年10月完全停用皮质类固醇。2019年10月1日,行经动脉化疗栓塞术(TACE),联合Gelaspon、Lipidol和阿霉素完全消融肝结节。两年后,患者出现Child-Pugh B肝硬化(评分7),无肿瘤复发。结论:Child-Pugh B肝硬化合并其他合并症患者行腹腔镜右肾上腺切除术是安全的,但在视频和超声引导下经皮酒精化肝结节需要TACE才能完全破坏。
{"title":"Laparoscopic Right Adrenalectomy for a Large Adrenal Tumor Combined with in situ Ablation of a Hepatic Nodule in a Cirrhotic Patient","authors":"Mirela Patricia Sîrbu Boeți, Andrei Marius Baicu, M. Toma, V. Herlea, L. Iliescu","doi":"10.21614/sgo-26-2-362","DOIUrl":"https://doi.org/10.21614/sgo-26-2-362","url":null,"abstract":"Introduction: Cirrhotic patients are difficult patients to operate on and are generally considered unsuitable for laparoscopy (1,2). We present the clinical case of a cirrhotic patient with comorbidities that was diagnosed with a hepatic nodule and cortisol secreting right adrenal tumor, for which a multidisciplinary team decided to submit him for laparoscopic intervention. Case report: N.D. is a 59 y.o. male, diagnosed in 2010 with alcoholic Child-Pugh B liver cirrhosis (score 9). In February 2019, a hepatic nodule in segment IV-A (2 cm) and cortisol secreting right adrenal tumor (6/4/4 cm) were found. He is also diagnosed with essential arterial hypertension grade II, mild diastolic dysfunction of the left ventricle, aortic sclerosis, chronic ischemic cardiomyopathy, type 2 diabetes mellitus and chronic gastritis. He had laparoscopic cholecystectomy in 2000. The hepatic nodule in segment IV-A was highly suggestive of hepatocellular carcinoma due to imaging characteristics. Subclinical secretion of cortisol was present (low ACTH 4.18 pg/ml, normal plasmatic cortisol, metanephrine, normetanephrine). AFP, CEA, CA 19-9 were normal. The patient underwent surgery on 27 May 2019. Adhesiolysis, transperitoneal laparoscopic right adrenalectomy and alcoholization of hepatic tumor have been performed. Radiofrequency ablation of the hepatic tumor was preoperatively anticipated but was intraoperatively abandoned in favor of in situ hepatic tumor ablation with percutaneous ethanol injection due to encountered metabolic acidosis and cardiac arrhythmia. Results: Postoperatively the patient developed hemorrhagic ascites and abdominal wall hematoma that were successfully controlled by conservative measurements. He was discharged on the 15 th postoperative day. Histopathology found cortical-adrenal adenoma with clear cells. The patient was completely withdrawn from corticosteroids in October 2019. On October 1st, 2019, transarterial chemoembolization (TACE) with Gelaspon, Lipidol and Doxorubicin was performed to completely ablate the hepatic nodule. After two years the patient had Child-Pugh B cirrhosis (score 7) with no tumor recurrence. Conclusion: Laparoscopic right adrenalectomy could be safely performed for a right adrenal tumor in a Child-Pugh B cirrhotic patient with other comorbidities but the percutaneous alcoholization of the hepatic nodule under video and ultrasound guidance needed TACE for its complete destruction.","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86650450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatic Artery Thrombosis in Liver Transplantation - Case Report and Literature Review 肝移植并发肝动脉血栓1例并文献复习
Q4 Medicine Pub Date : 2021-06-30 DOI: 10.21614/sgo-26-2-356
C. Picu, F. Botea, D. Hrehoreţ, S. Alexandrescu, R. Grigorie, V. Brașoveanu
We present a case of a 63-year-old male with HCC developed on viral cirrhosis (HVB-HVD) Child C, MELD 15 who was performed a cadaveric orthotopic liver transplantation (marginal graft previous perfused and oxygenated using the Liver Assist Device). After one month, in the context of a febrile episode, the patient was discovered a biliary stenosis associated with biliary fistulae for which he was placed a biliary stent (ERCP). The afterwards abdominal CT revealed absence of the visualization of the graft common hepatic artery and its intrahepatic branches. An arteriography in an emergency manner was performed, with administration of Actylise, and then continued with Ilomedin and Heparin administration, but with no improved imaging appearance. The patient underwent a liver retransplantation - the arterial anastomose was performed between the donor superior mesenteric artery (due to the anatomical variant: accessory right hepatic artery from superior mesenteric artery) and the recipient infrarenal aorta (using iliac cadaveric arterial graft). 18 months after the retransplantation, the CT scan revealed homogeneous hepatic graft and permeable vascular axis.
我们报告一例63岁男性HCC并发病毒性肝硬化(HVB-HVD), Child C, MELD 15,行尸体原位肝移植(边缘移植物先前使用肝辅助装置灌注和充氧)。1个月后,患者发热发作,发现胆道狭窄伴胆道瘘,并放置胆道支架(ERCP)。术后腹部CT显示移植肝总动脉及其肝内分支不见。在紧急情况下进行动脉造影,并给予actilise,然后继续给予伊洛美丁和肝素,但没有改善影像学表现。患者行肝脏再移植手术,在供体肠系膜上动脉(由于解剖变异:右肝副动脉来自肠系膜上动脉)与受体肾下主动脉(髂尸动脉移植)之间进行动脉吻合。再移植18个月后,CT扫描显示肝移植物均质,血管轴通透。
{"title":"Hepatic Artery Thrombosis in Liver Transplantation - Case Report and Literature Review","authors":"C. Picu, F. Botea, D. Hrehoreţ, S. Alexandrescu, R. Grigorie, V. Brașoveanu","doi":"10.21614/sgo-26-2-356","DOIUrl":"https://doi.org/10.21614/sgo-26-2-356","url":null,"abstract":"We present a case of a 63-year-old male with HCC developed on viral cirrhosis (HVB-HVD) Child C, MELD 15 who was performed a cadaveric orthotopic liver transplantation (marginal graft previous perfused and oxygenated using the Liver Assist Device). After one month, in the context of a febrile episode, the patient was discovered a biliary stenosis associated with biliary fistulae for which he was placed a biliary stent (ERCP). The afterwards abdominal CT revealed absence of the visualization of the graft common hepatic artery and its intrahepatic branches. An arteriography in an emergency manner was performed, with administration of Actylise, and then continued with Ilomedin and Heparin administration, but with no improved imaging appearance. The patient underwent a liver retransplantation - the arterial anastomose was performed between the donor superior mesenteric artery (due to the anatomical variant: accessory right hepatic artery from superior mesenteric artery) and the recipient infrarenal aorta (using iliac cadaveric arterial graft). 18 months after the retransplantation, the CT scan revealed homogeneous hepatic graft and permeable vascular axis.","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74954269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radio-Opaque Filaments Guided Bile Duct Division During Living Donor Liver Transplantation, a Simple Solution to an Ongoing Dilemma 活体肝移植过程中,无线电不透明灯丝引导胆管分割,一个解决持续困境的简单方法
Q4 Medicine Pub Date : 2021-06-30 DOI: 10.21614/sgo-26-2-259
A. Taha, Ramy A. Hassan, M. Mahdy, M. S. Abbas, N. Makhlouf, S. Hassaneen, Tameem M. Ibraheem
Background: We describe our experience with two techniques of bile duct division in donors of right lobe living donor liver transplantation (RL-LDLT). Methods: 49 RL-LDLT done in Al-Rajhi Liver Hospital, Assiut University, Egypt were divided into 2 eras; from November 2014 till September 2018, the site of biliary division in 29 donors was marked by metal clips (Clips group) and from October 2018 till September 2019, 20 donors were marked by radio-opaque filaments (ROF group). Results: There were no differences between groups in donors’ and recipients’ baseline characteristics. In ROF group there were less number of bile ducts stumps (2, range 1-3 versus 2 range 1-4 in Clips group, p=0.044), less number of “imprecise-transection” (1 (5%) versus 11 (37.9%) in Clips group, p=0.009) and fewer number intraoperative cholangiographies performed (1, range 1-2 versus 2 range 1-3 in Clips group, p=0.001). There were no differences between groups in the number of biliary anastomoses or incidence of biliary complications in donors or recipients. Median follow up is 33 months (range 8-66). Conclusions: Marking biliary division by ROF is a simple and minor modification but can decrease the difficulty of surgery and reduce exposure of donor and operating team to
背景:我们描述了我们在右叶活体肝移植(RL-LDLT)供者中使用两种胆管分割技术的经验。方法:49例在埃及Assiut大学Al-Rajhi肝脏医院完成的RL-LDLT分为2期;2014年11月至2018年9月,29例献血者用金属夹(clips组)标记胆道分治部位;2018年10月至2019年9月,20例献血者用放射性不透明丝(ROF组)标记胆道分治部位。结果:两组间供体和受体基线特征无差异。ROF组胆管残端数量较少(2例,范围1-3,clip组2例,范围1-4,p=0.044),“不精确断面”数量较少(1例(5%),clip组11例(37.9%),p=0.009),术中胆管造影次数较少(1例,范围1-2,clip组2例,范围1-3,p=0.001)。两组间供、受者的胆道吻合口数量和胆道并发症发生率均无差异。中位随访时间为33个月(8-66个月)。结论:ROF标记胆道分界是一种简便易行的改良方法,可降低手术难度,减少供体和手术团队的暴露
{"title":"Radio-Opaque Filaments Guided Bile Duct Division During Living Donor Liver Transplantation, a Simple Solution to an Ongoing Dilemma","authors":"A. Taha, Ramy A. Hassan, M. Mahdy, M. S. Abbas, N. Makhlouf, S. Hassaneen, Tameem M. Ibraheem","doi":"10.21614/sgo-26-2-259","DOIUrl":"https://doi.org/10.21614/sgo-26-2-259","url":null,"abstract":"Background: We describe our experience with two techniques of bile duct division in donors of right lobe living donor liver transplantation (RL-LDLT). Methods: 49 RL-LDLT done in Al-Rajhi Liver Hospital, Assiut University, Egypt were divided into 2 eras; from November 2014 till September 2018, the site of biliary division in 29 donors was marked by metal clips (Clips group) and from October 2018 till September 2019, 20 donors were marked by radio-opaque filaments (ROF group). Results: There were no differences between groups in donors’ and recipients’ baseline characteristics. In ROF group there were less number of bile ducts stumps (2, range 1-3 versus 2 range 1-4 in Clips group, p=0.044), less number of “imprecise-transection” (1 (5%) versus 11 (37.9%) in Clips group, p=0.009) and fewer number intraoperative cholangiographies performed (1, range 1-2 versus 2 range 1-3 in Clips group, p=0.001). There were no differences between groups in the number of biliary anastomoses or incidence of biliary complications in donors or recipients. Median follow up is 33 months (range 8-66). Conclusions: Marking biliary division by ROF is a simple and minor modification but can decrease the difficulty of surgery and reduce exposure of donor and operating team to","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85197083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Impact of Sustained Virological Response on Metabolic Profile and Kidney Function in Cured HCV Liver Transplant Recipients 持续病毒学反应对治愈HCV肝移植受者代谢特征和肾功能的影响
Q4 Medicine Pub Date : 2021-06-30 DOI: 10.21614/sgo-26-2-364
S. Iacob, M. Onica, R. Iacob, C. Gheorghe, S. Beckebaum, V. Cicinnati, I. Popescu, L. Gheorghe
Background: Long-term morbidity and mortality following liver transplantation (LT) is influenced by HCV-related extrahepatic complications and effects of immunosuppressive therapy. Aim: To investigate if sustained virological response (SVR) after therapy with direct acting antivirals (DAA) in recipients with post-transplant recurrent hepatitis C can influence metabolic factors and renal function. Methods: Metabolic profile, cardiovascular risk scores, non-invasive evaluation of fibrosis, renal function was assessed in 89 HCV LT recipients at SVR and 24 months after cure. Results: Liver stiffness measurement evaluated by transient elastography, APRI, FIB-4 and NAFLD fibrosis scores decreased significantly between baseline, SVR and 24 months after SVR. In contrast, BARD score increased significantly (p=0.001). Steatosis grade 3 was significantly encountered in a higher percentage at 24 months after SVR compared to baseline (77.5% vs 22.5%, p<0.0001). The metabolic and cardiovascular risk profile (MetS and Framingham scores), respectively, remained stable during the timeline. All liver function tests such as alanine and aspartate aminotransferase, gamma glutamyl transferase, total bilirubin improved between initiation of antivirals, SVR and 24 months after SVR; platelets increased significantly (p<0.0001 for each variable). The renal function evaluated by creatinine serum level (p=0.03) and estimated glomerular filtration rate (p=0.02) was significantly deteriorated over time. Conclusions: Eradication of recurrent HCV infection has a clear benefit for liver-related complications, but has no impact on HCV extrahepatic manifestations. Prospective studies with non-HCV cohorts are required to compare the impact of immunosuppression on metabolic and renal complications.
背景:肝移植(LT)术后的长期发病率和死亡率受到hcv相关肝外并发症和免疫抑制治疗效果的影响。目的:探讨丙型肝炎移植后复发患者接受直接抗病毒药物(DAA)治疗后的持续病毒学反应(SVR)是否会影响代谢因子和肾功能。方法:在SVR和治愈后24个月对89例HCV肝移植患者的代谢特征、心血管风险评分、无创纤维化评估和肾功能进行评估。结果:通过瞬时弹性图、APRI、FIB-4和NAFLD纤维化评分评估的肝脏硬度测量在基线、SVR和SVR后24个月之间显著下降。相比之下,BARD评分显著升高(p=0.001)。与基线相比,SVR后24个月出现3级脂肪变性的比例明显更高(77.5% vs 22.5%, p<0.0001)。代谢和心血管风险概况(MetS和Framingham评分)分别在时间轴上保持稳定。所有肝功能测试,如丙氨酸和天冬氨酸转氨酶、谷氨酰转移酶、总胆红素在开始抗病毒药物、SVR和SVR后24个月期间改善;血小板显著增加(各变量p<0.0001)。血清肌酐水平(p=0.03)和肾小球滤过率(p=0.02)评估的肾功能随着时间的推移而显著恶化。结论:根除复发性HCV感染对肝脏相关并发症有明显的益处,但对HCV肝外表现没有影响。需要对非hcv队列进行前瞻性研究,以比较免疫抑制对代谢和肾脏并发症的影响。
{"title":"Impact of Sustained Virological Response on Metabolic Profile and Kidney Function in Cured HCV Liver Transplant Recipients","authors":"S. Iacob, M. Onica, R. Iacob, C. Gheorghe, S. Beckebaum, V. Cicinnati, I. Popescu, L. Gheorghe","doi":"10.21614/sgo-26-2-364","DOIUrl":"https://doi.org/10.21614/sgo-26-2-364","url":null,"abstract":"Background: Long-term morbidity and mortality following liver transplantation (LT) is influenced by HCV-related extrahepatic complications and effects of immunosuppressive therapy. Aim: To investigate if sustained virological response (SVR) after therapy with direct acting antivirals (DAA) in recipients with post-transplant recurrent hepatitis C can influence metabolic factors and renal function. Methods: Metabolic profile, cardiovascular risk scores, non-invasive evaluation of fibrosis, renal function was assessed in 89 HCV LT recipients at SVR and 24 months after cure. Results: Liver stiffness measurement evaluated by transient elastography, APRI, FIB-4 and NAFLD fibrosis scores decreased significantly between baseline, SVR and 24 months after SVR. In contrast, BARD score increased significantly (p=0.001). Steatosis grade 3 was significantly encountered in a higher percentage at 24 months after SVR compared to baseline (77.5% vs 22.5%, p<0.0001). The metabolic and cardiovascular risk profile (MetS and Framingham scores), respectively, remained stable during the timeline. All liver function tests such as alanine and aspartate aminotransferase, gamma glutamyl transferase, total bilirubin improved between initiation of antivirals, SVR and 24 months after SVR; platelets increased significantly (p<0.0001 for each variable). The renal function evaluated by creatinine serum level (p=0.03) and estimated glomerular filtration rate (p=0.02) was significantly deteriorated over time. Conclusions: Eradication of recurrent HCV infection has a clear benefit for liver-related complications, but has no impact on HCV extrahepatic manifestations. Prospective studies with non-HCV cohorts are required to compare the impact of immunosuppression on metabolic and renal complications.","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72374693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comparison of Nutritional/Inflammatory Scores as a Preoperative Predictor of Short-Term Surgical Risks in Hepatectomy for Colorectal Metastasis 术前营养/炎症评分作为结肠转移肝切除术短期手术风险预测指标的比较
Q4 Medicine Pub Date : 2021-06-30 DOI: 10.21614/sgo-26-2-279
Ryosuke Umino, J. Shindoh, Yuta Kobayashi, Miho Akabane, Kazutaka Kojima, S. Okubo, M. Hashimoto
Background: Various nutritional/inflammatory scores reportedly correlate with surgical outcomes of abdominal surgery, while it remains inconclusive which one is the best in prediction of short-term surgical outcomes of patients with colorectal liver metastasis (CLM). Methods: Clinical records of 367 hepatectomies for 267 patients with CLM were retrospectively reviewed. Preoperative nutritional/inflammatory status was determined using 14 reported nutritional/inflammatory scores and predictive powers of these scores for short-term surgical outcomes were compared. Results: In receiver operating characteristics curve analysis, controlling nutritional status (CONUT) score showed the highest performance in prediction of major postoperative morbidity (area under the curve [AUC], 0.650) among the tested scores and similar tendency was also confirmed in prediction of global postoperative morbidity (AUC, 0.622). Multivariate analysis confirmed that the CONUT score showed significant correlation with both global morbidity (odds ratio [OR], 1.29; 95% CI, 1.11-1.49, P=0.001) and major morbidity (OR, 1.31; 95% CI, 1.08-1.60; P=0.006). When preoperative degree of malnutrition was classified into normal, light, and moderate according to the original CONUT scoring system, short-term surgical outcomes were well stratified as follows: any morbidity, 21.8% vs. 35.1% vs. 51.9% (P=0.001); major morbidity, 6.2% vs. 11.7% vs. 29.6% (P=0.002); and postoperative hospital stay, 11 days vs. 11 days vs. 12 days (P=0.006). Conclusions: The CONUT score could be a simple and reliable predictor of short-term surgical outcomes of patients undergoing hepatectomy for CLM.
背景:据报道,各种营养/炎症评分与腹部手术的手术结果相关,但哪一种评分在预测结直肠癌肝转移(CLM)患者的短期手术结果方面效果最好尚不明确。方法:回顾性分析267例CLM患者367例肝切除术的临床资料。术前营养/炎症状态通过14个报告的营养/炎症评分来确定,并比较这些评分对短期手术结果的预测能力。结果:在受试者工作特征曲线分析中,控制营养状况(CONUT)评分在预测术后主要发病率(曲线下面积[AUC], 0.650)方面表现最好,在预测术后总体发病率(AUC, 0.622)方面也有类似的趋势。多因素分析证实,CONUT评分与全球发病率均有显著相关性(优势比[OR], 1.29;95% CI, 1.11-1.49, P=0.001)和主要发病率(OR, 1.31;95% ci, 1.08-1.60;P = 0.006)。术前根据原始CONUT评分系统将营养不良程度分为正常、轻度和中度,短期手术结果分层如下:任何发病率,21.8% vs. 35.1% vs. 51.9% (P=0.001);重度发病率,6.2% vs. 11.7% vs. 29.6% (P=0.002);术后住院时间:11天vs. 11天vs. 12天(P=0.006)。结论:CONUT评分可以简单可靠地预测CLM肝切除术患者的短期手术结果。
{"title":"Comparison of Nutritional/Inflammatory Scores as a Preoperative Predictor of Short-Term Surgical Risks in Hepatectomy for Colorectal Metastasis","authors":"Ryosuke Umino, J. Shindoh, Yuta Kobayashi, Miho Akabane, Kazutaka Kojima, S. Okubo, M. Hashimoto","doi":"10.21614/sgo-26-2-279","DOIUrl":"https://doi.org/10.21614/sgo-26-2-279","url":null,"abstract":"Background: Various nutritional/inflammatory scores reportedly correlate with surgical outcomes of abdominal surgery, while it remains inconclusive which one is the best in prediction of short-term surgical outcomes of patients with colorectal liver metastasis (CLM). Methods: Clinical records of 367 hepatectomies for 267 patients with CLM were retrospectively reviewed. Preoperative nutritional/inflammatory status was determined using 14 reported nutritional/inflammatory scores and predictive powers of these scores for short-term surgical outcomes were compared. Results: In receiver operating characteristics curve analysis, controlling nutritional status (CONUT) score showed the highest performance in prediction of major postoperative morbidity (area under the curve [AUC], 0.650) among the tested scores and similar tendency was also confirmed in prediction of global postoperative morbidity (AUC, 0.622). Multivariate analysis confirmed that the CONUT score showed significant correlation with both global morbidity (odds ratio [OR], 1.29; 95% CI, 1.11-1.49, P=0.001) and major morbidity (OR, 1.31; 95% CI, 1.08-1.60; P=0.006). When preoperative degree of malnutrition was classified into normal, light, and moderate according to the original CONUT scoring system, short-term surgical outcomes were well stratified as follows: any morbidity, 21.8% vs. 35.1% vs. 51.9% (P=0.001); major morbidity, 6.2% vs. 11.7% vs. 29.6% (P=0.002); and postoperative hospital stay, 11 days vs. 11 days vs. 12 days (P=0.006). Conclusions: The CONUT score could be a simple and reliable predictor of short-term surgical outcomes of patients undergoing hepatectomy for CLM.","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73614723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pancreatic Enzyme Supplementation Improves Quality of Life in Patients Following Surgery for Upper GI Cancer 胰酶补充改善上消化道肿瘤手术后患者的生活质量
Q4 Medicine Pub Date : 2021-06-30 DOI: 10.21614/sgo-26-2-322
C. Alexander, R. Kay, Sajid Waheed Rahman, C. Deans
Background: Unpleasant abdominal symptoms are common following surgery for upper gastrointestinal (UGI) cancer and may occur secondary to pancreatic exocrine insufficiency (EPI). This study investigated symptoms of EPI in patients following surgery and assessed the effect of pancreatic enzyme supplementation (PERT) on these symptoms and the effect of supplementation on quality of life. Methods: Patients were assessed for symptoms of EPI using a novel questionnaire. Patients who reported two or more symptoms suggestive of EPI were prescribed PERT. Abdominal symptoms were reassessed following treatment. Quality of life (QoL) was studied using the SF-36 questionnaire before and after treatment. Faecal elastase was measured in a patient subgroup. Results: Fifty-six out of 57 patients (98%) reported at least two symptoms of EPI. Following PERT every patient reported fewer abdominal symptoms; median 5 symptoms before treatment reduced to two symptoms following treatment (p<0.0001; Wilcoxon rank). Reduced faecal elastase concentration was associated with more frequent abdominal symptoms; median 5 symptoms versus 3 symptoms (p = 0.043; Mann Whitney U test). PERT increased quality of life scores for every patient in each of the 5 principle health domains. Conclusion: Symptoms of EPI are common among patients following UGI cancer surgery. PERT reduces unpleasant abdominal symptoms and this leads to significant improvements in quality of life across global health domains. PERT should be offered to all post-operative UGI cancer patients with symptoms suggestive of EPI.
背景:不愉快的腹部症状是上胃肠道(UGI)癌手术后常见的症状,可能继发于胰腺外分泌功能不全(EPI)。本研究调查了手术后EPI患者的症状,并评估了胰酶补充(PERT)对这些症状的影响以及补充对生活质量的影响。方法:采用一种新颖的问卷对EPI患者的症状进行评估。报告两种或两种以上提示EPI症状的患者开PERT。治疗后重新评估腹部症状。采用SF-36问卷对治疗前后患者的生活质量(QoL)进行研究。在患者亚组中测量粪便弹性蛋白酶。结果:57例患者中有56例(98%)报告了至少两种EPI症状。采用PERT后,每位患者报告的腹部症状较少;治疗前中位症状5个,治疗后中位症状2个(p<0.0001;Wilcoxon排名)。粪便弹性酶浓度降低与更频繁的腹部症状相关;中位5种症状vs . 3种症状(p = 0.043;曼·惠特尼测试)。PERT提高了5个主要健康领域中每个患者的生活质量评分。结论:EPI症状在UGI肿瘤手术后患者中很常见。PERT可减少不愉快的腹部症状,从而显著改善全球卫生领域的生活质量。所有术后有EPI症状的UGI癌症患者应提供PERT。
{"title":"Pancreatic Enzyme Supplementation Improves Quality of Life in Patients Following Surgery for Upper GI Cancer","authors":"C. Alexander, R. Kay, Sajid Waheed Rahman, C. Deans","doi":"10.21614/sgo-26-2-322","DOIUrl":"https://doi.org/10.21614/sgo-26-2-322","url":null,"abstract":"Background: Unpleasant abdominal symptoms are common following surgery for upper gastrointestinal (UGI) cancer and may occur secondary to pancreatic exocrine insufficiency (EPI). This study investigated symptoms of EPI in patients following surgery and assessed the effect of pancreatic enzyme supplementation (PERT) on these symptoms and the effect of supplementation on quality of life. Methods: Patients were assessed for symptoms of EPI using a novel questionnaire. Patients who reported two or more symptoms suggestive of EPI were prescribed PERT. Abdominal symptoms were reassessed following treatment. Quality of life (QoL) was studied using the SF-36 questionnaire before and after treatment. Faecal elastase was measured in a patient subgroup. Results: Fifty-six out of 57 patients (98%) reported at least two symptoms of EPI. Following PERT every patient reported fewer abdominal symptoms; median 5 symptoms before treatment reduced to two symptoms following treatment (p<0.0001; Wilcoxon rank). Reduced faecal elastase concentration was associated with more frequent abdominal symptoms; median 5 symptoms versus 3 symptoms (p = 0.043; Mann Whitney U test). PERT increased quality of life scores for every patient in each of the 5 principle health domains. Conclusion: Symptoms of EPI are common among patients following UGI cancer surgery. PERT reduces unpleasant abdominal symptoms and this leads to significant improvements in quality of life across global health domains. PERT should be offered to all post-operative UGI cancer patients with symptoms suggestive of EPI.","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84228504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of a Single Oncoplastic Technique for Peri-Areolar Upper Quadrants Breast Cancer 乳晕周围上象限乳腺癌单一肿瘤成形术的评价
Q4 Medicine Pub Date : 2021-06-30 DOI: 10.21614/sgo-26-2-297
Mostafa M. Elghalban, M. Ghazaly, A. Darwish, A. Elnemr, W. Y. E. Sherpiny
Background: Oncoplastic surgery has gained wide popularity. Batwing mastopexy (BWM) is an oncoplastic technique being used in treatment of centrally located tumors. The purpose of our study is to assess short-term outcome including cosmetic results of this technique done for peri-areolar lesions in breast upper quadrants. Methods: A prospective study of a series of 25 women with upper quadrants peri-areolar breast cancer. 23 patients underwent wide local excision with clear margins accompanied by BWM in order to achieve pleasant outcome. Separate incisions were performed for axillary biopsy or dissection for invasive cancers. Four months after surgery, the cosmetic result was evaluated both objectively by the surgeons (five elements of the ABNSW system) and subjectively by patients regarding their satisfaction. Results: Results were rated as poor, fair, good or excellent. This revealed good result in 18 cases (78%) followed by fair in 4 cases (17%). Again, most patients 18 (78%) expressed good satisfaction with none of them reporting poor outcome either objectively by surgeons or even subjectively. Minor complications occurred in only 5 patients (21.7%), all have been treated conservatively. Conclusion: Batwing mastopexy is a safe, convenient-to-learn, and quick technique. It allows to achieve a favorable breast shape, particularly in women with large breasts.
背景:肿瘤整形手术已经得到了广泛的普及。蝙蝠翼乳房固定术(BWM)是一种用于治疗中心位置肿瘤的肿瘤整形技术。我们研究的目的是评估短期结果,包括该技术在乳房上象限乳晕周围病变的美容效果。方法:对25例上象限乳晕周围乳腺癌患者进行前瞻性研究。23例患者行边缘清晰的大面积局部切除伴BWM,以获得满意的结果。对浸润性肿瘤进行单独的腋窝活检或清扫。术后4个月,由外科医生(ABNSW系统的5个要素)客观评价美容效果,并由患者主观评价其满意度。结果:结果分为差、一般、良、优。结果良好18例(78%),一般4例(17%)。同样,大多数患者18(78%)表示满意,没有人报告手术结果不佳,无论是客观地还是主观地。轻微并发症仅5例(21.7%),均采用保守治疗。结论:蝙蝠翼乳房固定术是一种安全、易学、快捷的技术。它可以达到一个良好的乳房形状,特别是对于大乳房的女性。
{"title":"Evaluation of a Single Oncoplastic Technique for Peri-Areolar Upper Quadrants Breast Cancer","authors":"Mostafa M. Elghalban, M. Ghazaly, A. Darwish, A. Elnemr, W. Y. E. Sherpiny","doi":"10.21614/sgo-26-2-297","DOIUrl":"https://doi.org/10.21614/sgo-26-2-297","url":null,"abstract":"Background: Oncoplastic surgery has gained wide popularity. Batwing mastopexy (BWM) is an oncoplastic technique being used in treatment of centrally located tumors. The purpose of our study is to assess short-term outcome including cosmetic results of this technique done for peri-areolar lesions in breast upper quadrants. Methods: A prospective study of a series of 25 women with upper quadrants peri-areolar breast cancer. 23 patients underwent wide local excision with clear margins accompanied by BWM in order to achieve pleasant outcome. Separate incisions were performed for axillary biopsy or dissection for invasive cancers. Four months after surgery, the cosmetic result was evaluated both objectively by the surgeons (five elements of the ABNSW system) and subjectively by patients regarding their satisfaction. Results: Results were rated as poor, fair, good or excellent. This revealed good result in 18 cases (78%) followed by fair in 4 cases (17%). Again, most patients 18 (78%) expressed good satisfaction with none of them reporting poor outcome either objectively by surgeons or even subjectively. Minor complications occurred in only 5 patients (21.7%), all have been treated conservatively. Conclusion: Batwing mastopexy is a safe, convenient-to-learn, and quick technique. It allows to achieve a favorable breast shape, particularly in women with large breasts.","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74537265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biliary Complications Following Orthotopic Liver Transplantation: the Place of Surgical Reconstruction in the Minimally-Invasive Era 原位肝移植术后胆道并发症:微创时代手术重建的领域
Q4 Medicine Pub Date : 2021-03-31 DOI: 10.21614/SGO-26-309
Octavio A. Gil, Rodrigo Figueroa, M. Yance, F. Pascual, Joaquin Bastet, Rogelio A. Traverso, Carlos H Valenzuela
Background: Biliary complications are the more frequent problem following liver transplantation (LT) and have been considered the “Achiles´s heel”of this procedure. The aim of this study was to evaluate the rates of biliary complications after LT, the different therapeutic modalities currently available and their outcomes. Methods: A total of 420 LTs performed up to 2020 were retrospectively analyzed. Evaluation factors included MELD score, images, surgical techniques, type of biliary reconstruction and type of complications. We also analyzed the different therapeutic options, and the short and long-term outcome. Results: 417 deceased donors and 3 living donor transplants were performed. Biliary complications occurred in 37 patients (8,8%) – 31 strictures (81%), four leaks (11%), one acute biliary peritonitis after T-tube removal (3%) and two patients biliary stones (5%). Biliary complications associated with vascular complications were seen in 10 patients (27%). In general, a minimally invasive management (percutaneous or endoscopic) was the first-line approach. Percutaneous interventional procedures were the treatment of choice in 32/37 patients (86,48%), with a success rate of 67.74% (21/31). Hepaticojejunostomy (HJ) was performed in 14 patients. Overall morbidity rate of surgical reconstruction was 14% (2/14 patients) and perioperative mortality was 7%. The median follow–up was 54,53 months. At follow-up, none of the patients in the HJ group had developed a new stricture. Conclusions: The majority of biliary complications must be treated by minimally invasive approach. However, when those fail,surgical reconstruction allows to avoid future consequences in the graft.
背景:胆道并发症是肝移植(LT)术后更常见的问题,被认为是该手术的“阿基里斯之踵”。本研究的目的是评估肝移植后胆道并发症的发生率,目前可用的不同治疗方式及其结果。方法:回顾性分析截至2020年共420例LTs。评估因素包括MELD评分、影像、手术技术、胆道重建类型及并发症类型。我们还分析了不同的治疗方案,以及短期和长期的结果。结果:死亡供体417例,活体供体移植3例。发生胆道并发症37例(8.8%),狭窄31例(81%),漏4例(11%),t管拔除后急性胆道性腹膜炎1例(3%),胆结石2例(5%)。胆道并发症合并血管并发症10例(27%)。一般来说,微创治疗(经皮或内窥镜)是一线方法。32/37例(86.48%)患者选择经皮介入治疗,成功率67.74%(21/31)。14例患者行肝空肠吻合术。手术重建的总发病率为14%(2/14例),围手术期死亡率为7%。中位随访时间为54,53个月。在随访中,HJ组没有患者出现新的狭窄。结论:绝大多数胆道并发症必须采用微创入路治疗。然而,当这些失败时,手术重建可以避免移植物未来的后果。
{"title":"Biliary Complications Following Orthotopic Liver Transplantation: the Place of Surgical Reconstruction in the Minimally-Invasive Era","authors":"Octavio A. Gil, Rodrigo Figueroa, M. Yance, F. Pascual, Joaquin Bastet, Rogelio A. Traverso, Carlos H Valenzuela","doi":"10.21614/SGO-26-309","DOIUrl":"https://doi.org/10.21614/SGO-26-309","url":null,"abstract":"Background: Biliary complications are the more frequent problem following liver transplantation (LT) and have been considered the “Achiles´s heel”of this procedure. The aim of this study was to evaluate the rates of biliary complications after LT, the different therapeutic modalities currently available and their outcomes. Methods: A total of 420 LTs performed up to 2020 were retrospectively analyzed. Evaluation factors included MELD score, images, surgical techniques, type of biliary reconstruction and type of complications. We also analyzed the different therapeutic options, and the short and long-term outcome. Results: 417 deceased donors and 3 living donor transplants were performed. Biliary complications occurred in 37 patients (8,8%) – 31 strictures (81%), four leaks (11%), one acute biliary peritonitis after T-tube removal (3%) and two patients biliary stones (5%). Biliary complications associated with vascular complications were seen in 10 patients (27%). In general, a minimally invasive management (percutaneous or endoscopic) was the first-line approach. Percutaneous interventional procedures were the treatment of choice in 32/37 patients (86,48%), with a success rate of 67.74% (21/31). Hepaticojejunostomy (HJ) was performed in 14 patients. Overall morbidity rate of surgical reconstruction was 14% (2/14 patients) and perioperative mortality was 7%. The median follow–up was 54,53 months. At follow-up, none of the patients in the HJ group had developed a new stricture. Conclusions: The majority of biliary complications must be treated by minimally invasive approach. However, when those fail,surgical reconstruction allows to avoid future consequences in the graft.","PeriodicalId":22101,"journal":{"name":"Surgery, Gastroenterology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79029310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Surgery, Gastroenterology and Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1